Company Profile

FocalCool LLC
Profile last edited on: 12/14/2023      CAGE: 5TZB8      UEI: LDVFDX2N91G5

Business Identifier: Cooling catheters: therapeutic hypothermia
Year Founded
2004
First Award
2005
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

107 Gilbreth Parkway
Mullica Hill, NJ 08062
   (856) 256-4301
   jakers@focalcool.com
   www.focalcool.com
Location: Single
Congr. District: 02
County: Gloucester

Public Profile

FocalCool is a medical device company working on the develoment of cooling catheters that are designed quickly to reduce tissue temperature, minimizing organ damage resulting from ischemia. While reperfusion therapy and stents have created paradigm shifts in interventional care, FocalCool aims to create another shift -- directly addressing myocardial reperfusion injury. is working on an endovascular regional cooler for the heart. The firm is seeking th be able rapidly to cool heart tissue during emergency angioplasty. Their new guide catheter - CoolGuide - maintains the functionality of standard guide catheters, providing coronary artery access for devices like angioplasty catheters and stents, while also delivering targeted chilled blood to heart tissue at risk. It is also thought that therapeutic hypothermia could improve lives by saving seemingly tiny amounts of tissue at risk, enabling vital organs to continue working well.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Thomas L Merrill -- CEO and Co-Founder

  Jenn Akers

  Jay Yadav -- Chairman and Co-Founder

Company News

There are no news available.